Flenodic Im 25 mg/ml Injection
PDF Leaflet Revision Date: 06 November 2025
Clinical Summary
Quick overview from the medicine insert
Indication
Initial therapy for inflammatory and degenerative rheumatic disease.
Dosage (summary)
Adults: 75 mg once daily; severe cases: 75 mg twice daily.
Onset of Action / Duration
Onset: 30 mins, Duration: 6-8 hours
Special Populations
- Elderly
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Contraindicated in pregnancy and lactation; may impair fertility.
Key Drug Interactions
- Methotrexate
- Anticoagulants
- Lithium
- Digoxin
Contraindications
- Hypersensitivity to diclofenac
- Gastric or intestinal ulcer
- Severe renal impairment
- Active bleeding disorders
Common side effects
- Gastrointestinal bleeding
- Nausea
- Headache
- Dizziness
Counselling Points
- Use the lowest effective dose for the shortest duration
- Report any unusual abdominal symptoms
- Avoid use with other NSAIDs
Serious warnings
- Risk of gastrointestinal perforation
- Serious skin reactions
- Cardiovascular risks
On This Page
Loading package insert…
Medinsert AI
Hello! I am Medinsert Ai. What would you like to know about this professional information leaftleft?